Precision oncology exploits genomic, immunologic, and other biomarkers to drive discovery, drug development, and clinical care for patients with cancer. Precision oncology helps devise individualized ...
Statistical methods now being used in adaptive biomarker-driven clinical trials are reviewed. Some previous paradigms for clinical trial design can limit the development of more effective methods on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results